Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Future requirements for hematologists]

O Bruserud1, S Berentsen, I M Dahl

  • 1Medisinsk avdeling Haukeland Sykehus, Bergen.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|July 17, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation.

Clinical and experimental immunology·2018
Same author

A prospective observational study on effects of fever on red cell transfusion outcome.

Vox sanguinis·2017
Same author

Interleukin 4 (IL4), IL10 and IL13 Inhibit in vitro Cytokine Secretion by Acute Myelogenous Leukemia Blasts in the Presence of Exogenous Hematopoietic Growth Factors.

Hematology (Amsterdam, Netherlands)·2016
Same author

Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34(+) Cells in Multiple Myeloma Patients.

Hematology (Amsterdam, Netherlands)·2016
Same author

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.

Leukemia·2014
Same author

Differences in proliferative capacity of primary human acute myelogenous leukaemia cells are associated with altered gene expression profiles and can be used for subclassification of patients.

Cell proliferation·2013
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Correction: Management of acute epistaxis.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

A woman in her 70s with chest pain and elevated troponin T levels.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

More systematic follow-up after childbirth.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
Same journal

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2026
See all related articles

Norway faces a shortage of haematology specialists. To meet future needs, the Norwegian Society for Haematology recommends increasing the annual number of qualified specialists from 2.5 to ten for the next decade.

Area of Science:

  • Medical specialisation
  • Haematology
  • Healthcare workforce planning

Context:

  • Norway experiences a deficit in qualified haematology specialists.
  • The annual qualification rate between 1990-1995 was 2.5 specialists.
  • This rate is insufficient to meet current and future demands in Norwegian hospitals.

Purpose:

  • To address the projected shortage of haematology specialists in Norway.
  • To provide recommendations for increasing the number of qualified haematologists.
  • To ensure adequate specialist coverage in Norwegian municipal and university hospitals.

Summary:

  • The Norwegian Society for Haematology estimates a need for ten new haematology specialists per year over the next ten years.
  • This recommendation aims to bridge the gap between the current low qualification rate (2.5/year) and future healthcare requirements.

Related Experiment Videos

  • The proposed increase is crucial for maintaining essential haematological services across Norway.

    • Impact:

    • Enhance the capacity of Norwegian hospitals to provide specialized haematological care.
    • Mitigate the risks associated with specialist shortages, such as delayed diagnoses and treatment.
    • Strengthen the long-term sustainability of haematology services in Norway.